Lombard Odier Asset Management (Switzerland)’s Maravai LifeSciences MRVI Stock Holding History

Lombard Odier Asset Management (Switzerland)’s Portfolio MRVI Stock Details MRVI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-405,321	Closed	-$5.68M	–	297
2023 Q1	$5.68M	Buy	405,321 +169,799	+72%	+$2.44M	0.5%	56
2022 Q4	$3.37M	Hold	235,522	–	–	0.27%	81
2022 Q3	$6.01M	Buy	+235,522	New	+$5.91M	0.51%	54
2022 Q2	–	Sell	-37,000	Closed	-$1.3M	–	332
2022 Q1	$1.3M	Buy	+37,000	New	+$1.24M	0.1%	117

Other funds holding MRVI

GTCR LLC Chicago, Illinois $3.78B AUM 27.82% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

1WCM

12 West Capital Management New York $592M AUM 40.75% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Lombard Odier Asset Management (Switzerland)'s MRVI Position: Q2 2023 in Review

Lombard Odier Asset Management (Switzerland) sold out of Maravai LifeSciences (MRVI) in Q2 2023, closing a stake of 405,321 shares — an estimated $5.68M sold.

Lombard Odier Asset Management (Switzerland) first reported a position in MRVI in Q1 2022 and held it in 4 quarters. The position peaked at $6.01M in Q3 2022. 222 funds tracked by Wall St. Rank hold MRVI as of Q2 2023.

Lombard Odier Asset Management (Switzerland) reported no remaining Maravai LifeSciences position as of Q2 2023 after selling out during the quarter.
Lombard Odier Asset Management (Switzerland) sold 405,321 Maravai LifeSciences shares in Q2 2023, an estimated $5.68M.
Lombard Odier Asset Management (Switzerland) first reported a position in Maravai LifeSciences in Q1 2022 and held it in 4 quarters.
Lombard Odier Asset Management (Switzerland)'s Maravai LifeSciences position peaked at $6.01M in Q3 2022.
222 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q2 2023.

Based on Lombard Odier Asset Management (Switzerland)'s 13F filing for Q2 2023, filed 14 Aug 2023.